The pharmacokinetics of melphalan in patients with multiple myeloma: An intravenous/oral study using a conventional dose regimen

European Journal of Clinical Pharmacology

Volumn 24, Issue 2, 1983, Pages 283-285

  Woodhouse, K W ^b   Hamilton, P ^a   Lennard, A ^a   Rawlins, M D ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NONE

Author keywords

i.v. dosing; melphalan; myeloma; oral dosing; pharmacokinetics

Indexed keywords

MELPHALAN;

BLOOD AND HEMOPOIETIC SYSTEM; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DRUG DOSE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MULTIPLE MYELOMA; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; THERAPY;

ADMINISTRATION, ORAL; ADULT; AGED; HUMAN; INJECTIONS, INTRAVENOUS; KINETICS; MALE; MELPHALAN; MIDDLE AGE; MULTIPLE MYELOMA; SUPPORT, NON-U.S. GOV'T;

EID: 0020677084     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/BF00613833     Document Type: Article

References (8)

1. Kinetics of intravenous melphalan
2. Oral melphalan kinetics
3. L-phenylalamine mustard (L-PAM) in the management of primary breast cancer: a report of early findings
4. Glomerular filtration rate and creatinine clearance
5. Chemotherapy in advanced ovarian cancer
6. Advances in chemotherapy for gynecological cancer